SciSight Ecosystem
WoS SCIE Q1Hybrid

Atherosclerosis Supplements

Abbreviation (ISO):ATHEROSCLEROSIS SUPP
Country: Ireland•WoS SCIE Quartile: Q1•Identifier (ISSN):1567-5688(Print)/1878-5050(Online)•Articles / Year: 21
Clarivate Impact Factor (IF 2024)Q1
N/A

Leading citation impact metric from Clarivate Journal Citation Reports

H-Index (2021)
46

46 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation RateN/A
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
21articles/year
34.15% Gold OA•0% Original Research

Aims & Scope

Atherosclerosis brings together, from all sources, papers concerned with investigation on atherosclerosis, its risk factors and clinical manifestations.

Topics Covered (Recognized by AI)
Medicine94.2%Internal medicine85.1%Biology83.2%Chemistry62%Endocrinology59.2%Biochemistry55.8%Genetics37.3%Cardiology31.8%Pathology31.2%Cholesterol23.4%Psychology20.5%Physics20.1%

SCImago & Scopus Journal Intelligence

Not indexed in SCImago / Scopus database

This journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
Updating
Minor Category (Specific Field):
Updating
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
12.9周
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Elsevier Ireland Ltd
Publication Language
English
Frequency
Bimonthly
Founding Year
2000
Editorial Address
ELSEVIER IRELAND LTD, ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, IRELAND, 00000
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

17 year
YearImpact FactorArticles / YearTotal Citations
20250——
20241.585——
20233.235——
20223.968——
20212.35——
20203.07821188
2019—73348
2018—527380
2017—1071,148
2016—4359
2015—601,068
2014—7192
2013—421,051
2012—2102
2011—889879
2010—1,113809
2009—1,841876
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Atherosclerosis Supplements

WoS Q1
02352020202120222023202420250.00
Annual Impact Factor Metric
2025:0

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Circulation
IF: 41.3Q1
60% MatchExplore →
Lancet
IF: 109Q1
27% MatchExplore →
Record UUID: 78cf8409-076c-47df-b2f6-3e4ca139db65
Database Updated: 2026-10-01